LUNG Q2 2022 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$14M+14.3% YoY

Gross Profit

$10M74.7% margin

Operating Income

-$14M-103.3% margin

Net Income

-$15M-104.9% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

+29.3%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$213M

Total Liabilities

$41M

Stockholders' Equity

$172M

Cash & Equivalents

$122M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$12M	+14.3%
Gross Profit	$10M	$9M	+15.4%
Operating Income	-$14M	-$13M	-13.6%
Net Income	-$15M	-$13M	-12.9%

Geographic Segments

UNITED STATES

$9M62%

EMEA

$5M33%

Asia Pacific

$724,0005%

Other International Geographical Areas

$40,0000%